CONMED Corporation (CNMD)
- Previous Close
55.91 - Open
56.12 - Bid --
- Ask --
- Day's Range
54.83 - 56.78 - 52 Week Range
46.00 - 78.58 - Volume
379,794 - Avg. Volume
543,059 - Market Cap (intraday)
1.733B - Beta (5Y Monthly) 1.19
- PE Ratio (TTM)
14.70 - EPS (TTM)
3.81 - Earnings Date Jul 29, 2025 - Aug 4, 2025
- Forward Dividend & Yield 0.80 (1.43%)
- Ex-Dividend Date Mar 14, 2025
- 1y Target Est
64.14
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures in the United States and internationally. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries. It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands. It also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name. In addition, the company offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories. Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention; and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.
www.conmed.comRecent News: CNMD
View MorePerformance Overview: CNMD
Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CNMD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CNMD
View MoreValuation Measures
Market Cap
1.73B
Enterprise Value
2.59B
Trailing P/E
14.70
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.32
Price/Book (mrq)
1.77
Enterprise Value/Revenue
1.97
Enterprise Value/EBITDA
10.22
Financial Highlights
Profitability and Income Statement
Profit Margin
9.02%
Return on Assets (ttm)
4.14%
Return on Equity (ttm)
12.96%
Revenue (ttm)
1.32B
Net Income Avi to Common (ttm)
118.75M
Diluted EPS (ttm)
3.81
Balance Sheet and Cash Flow
Total Cash (mrq)
35.48M
Total Debt/Equity (mrq)
91.26%
Levered Free Cash Flow (ttm)
159.07M